Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Paediatric immune-mediated renal disease: an overview.

Oni L.

Nephrol Dial Transplant. 2019 Oct 5. pii: gfz184. doi: 10.1093/ndt/gfz184. [Epub ahead of print] No abstract available.

PMID:
31586428
2.

Childhood IgA Vasculitis (Henoch Schonlein Purpura)-Advances and Knowledge Gaps.

Oni L, Sampath S.

Front Pediatr. 2019 Jun 27;7:257. doi: 10.3389/fped.2019.00257. eCollection 2019. Review.

3.

Immunoglobulin replacement for secondary immunodeficiency after B-cell targeted therapies in autoimmune rheumatic disease: Systematic literature review.

Wijetilleka S, Mukhtyar C, Jayne D, Ala A, Bright P, Chinoy H, Harper L, Kazmi M, Kiani-Alikhan S, Li C, Misbah S, Oni L, Price-Kuehne F, Salama A, Workman S, Wrench D, Karim MY.

Autoimmun Rev. 2019 May;18(5):535-541. doi: 10.1016/j.autrev.2019.03.010. Epub 2019 Mar 4.

PMID:
30844552
4.

Working together to deliver stratified medicine research effectively.

Attar SG, Poustie VJ, Smye SW, Beety JM, Hawcutt DB, Littlewood S, Oni L, Pirmohamed M, Beresford MW.

Br Med Bull. 2019 Mar 1;129(1):107-116. doi: 10.1093/bmb/ldz003. Review.

PMID:
30753334
5.

Recommendations for the management of secondary hypogammaglobulinaemia due to B cell targeted therapies in autoimmune rheumatic diseases.

Wijetilleka S, Jayne DR, Mukhtyar C, Ala A, Bright PD, Chinoy H, Harper L, Kazmi MA, Kiani-Alikhan S, Li CK, Misbah SA, Oni L, Price-Kuehne FE, Salama AD, Workman S, Wrench D, Karim MY.

Rheumatology (Oxford). 2019 May 1;58(5):889-896. doi: 10.1093/rheumatology/key394.

PMID:
30590695
6.

Identifying cisplatin-induced kidney damage in paediatric oncology patients.

Barton CD, Pizer B, Jones C, Oni L, Pirmohamed M, Hawcutt DB.

Pediatr Nephrol. 2018 Sep;33(9):1467-1474. doi: 10.1007/s00467-017-3765-6. Epub 2017 Aug 18. Review.

7.

Inter-observer variability of the histological classification of lupus glomerulonephritis in children.

Oni L, Beresford MW, Witte D, Chatzitolios A, Sebire N, Abulaban K, Shukla R, Ying J, Brunner HI.

Lupus. 2017 Oct;26(11):1205-1211. doi: 10.1177/0961203317706558. Epub 2017 May 7.

PMID:
28478696
8.

Optimising the use of medicines to reduce acute kidney injury in children and babies.

Oni L, Hawcutt DB, Turner MA, Beresford MW, McWilliam S, Barton C, Park BK, Murray P, Wilm B, Copple I, Floyd R, Peak M, Sharma A, Antoine DJ.

Pharmacol Ther. 2017 Jun;174:55-62. doi: 10.1016/j.pharmthera.2017.02.018. Epub 2017 Feb 12. Review.

PMID:
28202365
9.

Paediatric anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis: an update on renal management.

Plumb LA, Oni L, Marks SD, Tullus K.

Pediatr Nephrol. 2018 Jan;33(1):25-39. doi: 10.1007/s00467-016-3559-2. Epub 2017 Jan 6. Review.

10.

International validation of a urinary biomarker panel for identification of active lupus nephritis in children.

Smith EM, Jorgensen AL, Midgley A, Oni L, Goilav B, Putterman C, Wahezi D, Rubinstein T, Ekdawy D, Corkhill R, Jones CA, Marks SD, Newland P, Pilkington C, Tullus K, Beresford MW.

Pediatr Nephrol. 2017 Feb;32(2):283-295. doi: 10.1007/s00467-016-3485-3. Epub 2016 Sep 3.

11.

The dual-tracer stable isotope method to measure calcium absorption in children on dialysis: a new use for an old technique.

Ware NA, Oni L, O'Brien KO, Abrams SA, Rees L.

Pediatr Nephrol. 2016 Oct;31(10):1713-4. doi: 10.1007/s00467-016-3435-0. Epub 2016 Jun 25. No abstract available.

PMID:
27344561
12.

Pharmacological Management of Childhood-Onset Systemic Lupus Erythematosus.

Thorbinson C, Oni L, Smith E, Midgley A, Beresford MW.

Paediatr Drugs. 2016 Jun;18(3):181-95. doi: 10.1007/s40272-016-0170-8. Review.

PMID:
26971103
13.

Increased concentration of plasma TNFR1 and TNFR2 in paediatric lupus nephritis.

Patel M, Oni L, Midgley A, Smith E, Tullus K, Marks SD, Jones CA, Pilkington C, Beresford MW.

Lupus. 2016 Aug;25(9):1040-4. doi: 10.1177/0961203316631634. Epub 2016 Feb 6.

PMID:
26854079
14.

Patients' views on improving sickle cell disease management in primary care: focus group discussion.

Aljuburi G, Phekoo KJ, Okoye NO, Anie K, Green SA, Nkohkwo A, Ojeer P, Ndive C, Banarsee R, Oni L, Majeed A.

JRSM Short Rep. 2012 Dec;3(12):84. doi: 10.1258/shorts.2012.011153. Epub 2012 Dec 27.

15.

Views of patients about sickle cell disease management in primary care: a questionnaire-based pilot study.

Aljuburi G, Okoye O, Majeed A, Knight Y, Green S, Banarsee R, Nkohkwo A, Ojeer P, Ndive C, Oni L, Phekoo K.

JRSM Short Rep. 2012 Nov;3(11):78. doi: 10.1258/shorts.2012.011173. Epub 2012 Nov 30.

16.

A sickle cell milestone.

Oni L.

Br J Nurs. 2009 Jul 23-Aug 12;18(14):842. No abstract available.

PMID:
19633593
17.

Antenatal screening for haemoglobinopathies in primary care: a whole system participatory action research project.

Thomas P, Oni L, Alli M, St Hilaire J, Smith A, Leavey C, Banarsee R.

Br J Gen Pract. 2005 Jun;55(515):424-8.

18.

Sickle cell disease.

Oni L, Bent S.

Nurs Times. 1998 Sep 16-22;94(37):50-3. Review. No abstract available.

PMID:
9832789
19.

Sickle cell disease and the carer-client relationship.

Oni L.

Nurs Times. 1998 Jul 1-7;94(26):64-5. Review. No abstract available.

PMID:
9739712
20.

Fair shares for London.

Maxwell K, Streetly A, Oni L.

Mod Midwife. 1997 Nov;7(11):15-9. No abstract available.

PMID:
9470698
21.

Management of patients with sickle cell disease.

Davies SC, Oni L.

BMJ. 1997 Sep 13;315(7109):656-60. Review. No abstract available.

22.

Neonatal screening for haemoglobin variants using filter paper-dried blood specimens.

Henderson SJ, Fishlock K, Horn ME, Oni L, Bellingham AJ.

Clin Lab Haematol. 1991;13(4):327-34.

PMID:
1773586

Supplemental Content

Support Center